- Home
- OABI vs CMPS Comparison
OABI vs CMPS Comparison
Compare OABI & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- CMPS
- Stock Information
- Founded
- OABI 2012
- CMPS 2020
- Country
- OABI United States
- CMPS United Kingdom
- Employees
- OABI N/A
- CMPS 186
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- OABI Health Care
- CMPS Health Care
- Exchange
- OABI Nasdaq
- CMPS Nasdaq
- Market Cap
- OABI 459.1M
- CMPS 362.6M
- IPO Year
- OABI N/A
- CMPS 2020
- Fundamental
- Price
- OABI $4.53
- CMPS $5.24
- Analyst Decision
- OABI Strong Buy
- CMPS Strong Buy
- Analyst Count
- OABI 4
- CMPS 7
- Target Price
- OABI $9.00
- CMPS $40.67
- AVG Volume (30 Days)
- OABI 349.2K
- CMPS 1.1M
- Earning Date
- OABI 11-12-2024
- CMPS 10-31-2024
- Dividend Yield
- OABI N/A
- CMPS N/A
- EPS Growth
- OABI N/A
- CMPS N/A
- EPS
- OABI N/A
- CMPS N/A
- Revenue
- OABI $21,714,000.00
- CMPS N/A
- Revenue This Year
- OABI N/A
- CMPS N/A
- Revenue Next Year
- OABI $71.78
- CMPS N/A
- P/E Ratio
- OABI N/A
- CMPS N/A
- Revenue Growth
- OABI N/A
- CMPS N/A
- 52 Week Low
- OABI $3.56
- CMPS $4.05
- 52 Week High
- OABI $6.72
- CMPS $12.75
- Technical
- Relative Strength Index (RSI)
- OABI 73.77
- CMPS 40.02
- Support Level
- OABI $4.04
- CMPS $4.19
- Resistance Level
- OABI $4.87
- CMPS $5.47
- Average True Range (ATR)
- OABI 0.18
- CMPS 0.36
- MACD
- OABI 0.10
- CMPS -0.07
- Stochastic Oscillator
- OABI 86.09
- CMPS 46.48
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.